MedPath
NMPA Approval

Aponermin for Injection

国药准字S20230063

November 1, 2023

Drug Information

注射用埃普奈明

沙艾特

注射剂

100mg(8,000,000U)/瓶

生物制品

November 1, 2023

Company Information

Applicant Company

武汉经济技术开发区海特科技园

Manufacturing Company

湖北省武汉经济技术开发区海特科技园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用埃普奈明 - NMPA 批准文号 | MedPath